Summary Sino Biopharmaceutical Limited (Sino) is a pharmaceutical company that develops, manufactures and markets a range of Chinese medicines and chemical medicines. The company manufactures, sells and distributes modernized Chinese medicine products and western medicine products. It provides long term investment services. Sinos products include tianqingganan injections for cardio-cerebral; runzhong dispersible tablets for hepatitis; and renyi pamidronate disodium injections. The company develops medicines for the treatment of tumors, diabetes, analgesia, respiratory system diseases, and others. It markets its products through its distributors. Sino is headquartered in Wanchai, Hong Kong. Sino Biopharmaceutical Limited (1177) Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report... Research Beam Model: Research Beam Product ID: 663093 250 USD New
Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Sino Biopharmaceutical Limited (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : May   2016
  • Pages : 23
  • Publisher : GlobalData
 
 
 
Summary

Sino Biopharmaceutical Limited (Sino) is a pharmaceutical company that develops, manufactures and markets a range of Chinese medicines and chemical medicines. The company manufactures, sells and distributes modernized Chinese medicine products and western medicine products. It provides long term investment services. Sinos products include tianqingganan injections for cardio-cerebral; runzhong dispersible tablets for hepatitis; and renyi pamidronate disodium injections. The company develops medicines for the treatment of tumors, diabetes, analgesia, respiratory system diseases, and others. It markets its products through its distributors. Sino is headquartered in Wanchai, Hong Kong.

Sino Biopharmaceutical Limited (1177) Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
Business Description A brief description of the company's operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Sino Biopharmaceutical Limited, Medical Devices Deals, 2010 to YTD 2016 9
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Sino BioPharma Acquires 52% Stake In Shaoyang Orthopedic Hospital For US$10.2 Million 11
Licensing Agreements 12
BioLineRx Enters Into Licensing Agreement with Jiangsu Chia-tai Tianqing Pharma For BL-8030 12
Equity Offering 14
Sino BioPharma Completes Private Placement Of US$79 Million 14
Sino BioPharma Completes Private Placement Of US$69 Million 16
Acquisition 18
Sino Biopharma To Acquire Additional 25% Stake In Jiangsu Chia Tai-Tianqing And Yancheng Suhai 18
Sino Biopharmaceutical Limited - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables
List of Tables
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Key Facts, 2014 1
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sino Biopharmaceutical Limited, Deals By Therapy Area, 2010 to YTD 2016 8
Sino Biopharmaceutical Limited, Medical Devices Deals, 2010 to YTD 2016 9
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Sino BioPharma Acquires 52% Stake In Shaoyang Orthopedic Hospital For US$10.2 Million 11
BioLineRx Enters Into Licensing Agreement with Jiangsu Chia-tai Tianqing Pharma For BL-8030 12
Sino BioPharma Completes Private Placement Of US$79 Million 14
Sino BioPharma Completes Private Placement Of US$69 Million 16
Sino Biopharma To Acquire Additional 25% Stake In Jiangsu Chia Tai-Tianqing And Yancheng Suhai 18
Sino Biopharmaceutical Limited, Key Competitors 19
Sino Biopharmaceutical Limited, Key Employees 20
Sino Biopharmaceutical Limited, Other Locations 21
Sino Biopharmaceutical Limited, Subsidiaries 21

List Of Figures
List of Figures
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sino Biopharmaceutical Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Sino Biopharmaceutical Limited, Medical Devices Deals, 2010 to YTD 2016 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter